<DOC>
	<DOCNO>NCT01413542</DOCNO>
	<brief_summary>The investigator would like find sitagliptin ( dipeptidyl peptidase-4 DPP4 inhibition ) , drug treat diabetes , affect blood vessel relaxation healthy people receive enalapril ( angiotensin convert enzyme ACE inhibition ) , blood pressure medicine . Understanding drug interact healthy people help u learn potential effect people diabetes .</brief_summary>
	<brief_title>Pharmacogenetics Ace Inhibitor-Associated Angioedema</brief_title>
	<detailed_description>To test hypothesis DPPIV inhibition sitagliptin potentiate vasodilator response substance P presence ACE inhibition enalaprilat BNP GLP-1 even presence ACE inhibition . The aim promise provide important new data regard mechanism action DPPIV inhibitor interactive effect two drug class use grow population diabetic patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<mesh_term>Kininogens</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<mesh_term>Dipeptidyl-Peptidase IV Inhibitors</mesh_term>
	<criteria>Age 18 65 inclusive Men woman Black White Americans BMI &lt; 25 For female subject : Postmenopausal status least 1 year Status post surgical sterilization If childbearing potential , utilization barrier method birth control willingness undergo blood Bhcg test prior drug treatment every study day Smoking Diabetes type 1 2 , define fast glucose 126 mg/dl great use antidiabetic medication Hypertension define untreated seated SBP great 140 mmHg untreated DBP great 90 mmHg use antihypertensives History report record hypoglycemia ( plasma glucose less 70 mg/dl ) Pregnancy Breastfeeding Use hormone replacement therapy The use contraceptive therapy Use medication multivitamin Hematocrit &lt; 35 % Cardiovascular disease history myocardial infarction , presence angina pectoris , significant arrhythmia , congestive heart failure ( LV hypertrophy acceptable ) , deep vein thrombosis , pulmonary embolism , second third degree heart block , mitral valve stenosis , aortic stenosis hypertrophic cardiomyopathy Asthma History angioedema History cough side effect ACE inhibitor use Impaired renal function , define eGFR &lt; 60ml/min/1.73M2 Clinically significant gastrointestinal impairment could interfere drug absorption Impaired hepatic function ( aspartate amino transaminase [ AST ] and/or alanine amino transferase [ ALT ] &gt; 2 x upper limit normal range History alcohol drug abuse Treatment investigational drug 1 month precede study Mental condition render subject unable understand nature , scope possible consequence study Inability comply protocol , e.g. , uncooperative attitude , inability return followup visit , unlikelihood completing study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>DPPIV inhibitor</keyword>
	<keyword>ACE inhibitor</keyword>
	<keyword>Bradykinin</keyword>
	<keyword>glucagon-like peptide ( GLP-1 )</keyword>
	<keyword>BNP</keyword>
	<keyword>diabetes</keyword>
	<keyword>hypertension</keyword>
</DOC>